Navigation Links
Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation

WESTFORD, Mass., Cynosure, Inc., a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced the launch of a new, higher power Smartlipo LaserBodySculpting (SM) Workstation. The new 10-watt workstation is intended for high-volume aesthetic laser practices, allowing a physician to complete a typical laser-assisted liposuction procedure in about half the time as the original 6-watt workstation.

"Cynosure's new 10-watt Smartlipo workstation allows me to treat patients quickly and efficiently, with the same level of safety and efficacy as the 6- watt system," said Bruce Katz, M.D., founder of New York's Juva Skin & Laser Center. "For example, an area of localized fat under the chin can be treated in about eight minutes with the 10-watt Smartlipo system, compared with about 15 minutes with the 6-watt workstation."

Introduced by Cynosure in January, the minimally invasive Smartlipo workstation is an innovative system designed as an alternative to traditional liposuction in patients with smaller areas of localized fat. The system's proprietary pulsing format delivers laser energy that liquefies localized deposits of fat that is then removed through a cannula.

In addition the laser energy coagulates the tissue, thereby sculpting body contours and tightening the skin. The procedure generally causes less bleeding, swelling and bruising than traditional liposuction, resulting in fewer complications and faster recovery. Cynosure received U.S. Food and Drug Administration clearance to market Smartlipo in the fourth quarter of 2006.

According to cosmetic surgeon Robert Gotkin, M.D., co-director of Cosmetique in New York, "The introduction of its new, higher power Smartlipo reflects Cynosure's commitment to advance its customers' practices with innovative products designed for patient efficiency."

"We believe the introduction of the 10-watt platform will acc elerate the adoption of Smartlipo in the marketplace," said Cynosure President and Chief Executive Officer Michael Davin. "We have been very pleased with the response to Smartlipo. Due to the short and minimally invasive nature of the Smartlipo treatment, patients who may have never considered traditional liposuction are having Smartlipo procedures performed."

"We believe that expanding our family of products with a more powerful version of the Smartlipo workstation will enhance our competitive position," Davin said. "The faster treatment times afforded by this 10-watt platform will be attractive to medical professionals, particularly those with high- volume practices."

The 10-watt Smartlipo workstation is available as a standalone unit or as an upgrade to the 6-watt system. Cynosure previously announced that it has added a 10-person specialty surgical sales force to market its Smartlipo family of workstations in North America.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite.

Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.


'"/>




Related medicine news :

1. TI Cycles Introduces Foldman
2. Canada Introduces Mandatory Nutrition Labeling
3. Cuba Introduces New Device for Detecting Vascular Diseases
4. China Introduces Solar-powered Baths
5. Allergan Introduces ‘Dermal Filler’ for Smile Lins
6. UAE Introduces Cervical Cancer Vaccine
7. Iceland Introduces Smoking Ban in Bars and Restaurants
8. Higher Risk of Asthma in children with autoimmune disease
9. Death Risk Higher in Obese Women with Colon Cancer
10. Women With Diabetes Have a Higher Risk of Depression
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... 2017 , ... As part of the nationwide Days of Remembrance effort led ... Holocaust and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced ... trip to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip ...
(Date:4/24/2017)... TX (PRWEB) , ... April 24, 2017 , ... The ... the glitterati, those unreal icons inhabiting the rarified air of pop and film stardom.(1) ... paparazzi and anyone snapping pictures: the smile. Grins now run the gamut from being ...
(Date:4/24/2017)... ... ... The California Dental Association Foundation’s two-day volunteer dental clinic, CDA Cares ... April 22-23 event at the San Mateo Event Center. , In addition to ... Cares educates the public and policymakers about the importance of good oral health and ...
(Date:4/24/2017)... ... ... Veteran Theresa James awoke to the sound of her newly ex-husband breaking ... James depicts every parent’s worst nightmare, when her three children were violently taken from ... throughout my divorce,” James said. “After the death of my children, I continued to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP Nutrition®, ... supplements, announced its popular products are now available for purchase on StackedNutrition.com, a ... the use of premium natural ingredients in making all of its products. These ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... 19, 2017  SARES•REGIS Group leased the first ... at Conejo Spectrum Business Park in ... Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful ... that have been underserved by scientific innovation, with ... cancer, autoimmune and infectious disease. Before ...
Breaking Medicine Technology: